MIM
AGL icon

MetLife Investment Management’s Agilon Health AGL Stock Holding History

MetLife Investment Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,312
Closed -$57K – 2767
2025
Q4 		$57K Sell
3,312
-2,946
-47% -$57.1K ﹤0.01% 2720
2025
Q3 		$161K Sell
6,258
-1,182
-16% -$44.7K ﹤0.01% 2430
2025
Q2 		$428K Buy
7,440
+5
+0.1% +$401 ﹤0.01% 1758
2025
Q1 		$805K Buy
7,435
+453
+6% +$39.4K ﹤0.01% 1468
2024
Q4 		$332K Buy
6,982
+270
+4% +$16.3K ﹤0.01% 2015
2024
Q3 		$659K Buy
6,712
+3,587
+115% +$463K ﹤0.01% 1630
2024
Q2 		$511K Buy
3,125
+2,470
+377% +$352K ﹤0.01% 1711
2024
Q1 		$99.9K Buy
655
+2
+0.3% +$333 ﹤0.01% 2539
2023
Q4 		$205K Sell
653
-9
-1% -$3.26K ﹤0.01% 2232
2023
Q3 		$294K Buy
662
+33
+5% +$14.9K ﹤0.01% 1969
2023
Q2 		$273K Buy
629
+191
+44% +$107K ﹤0.01% 2074
2023
Q1 		$260K Buy
438
+1
+0.2% +$560 ﹤0.01% 2066
2022
Q4 		$176K Sell
437
-11
-2% -$5.16K ﹤0.01% 2324
2022
Q3 		$263K Buy
448
+4
+0.9% +$2.4K ﹤0.01% 2113
2022
Q2 		$242K Buy
444
+31
+8% +$15.7K ﹤0.01% 2182
2022
Q1 		$262K Buy
+413
New +$213K ﹤0.01% 2184

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MetLife Investment Management's AGL Position: Q1 2026 in Review

MetLife Investment Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 3,312 shares — an estimated $57K sold.

MetLife Investment Management first reported a position in AGL in Q1 2022 and held it in 16 quarters. The position peaked at $805K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • MetLife Investment Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 3,312 Agilon Health shares in Q1 2026, an estimated $57K.
  • MetLife Investment Management first reported a position in Agilon Health in Q1 2022 and held it in 16 quarters.
  • MetLife Investment Management's Agilon Health position peaked at $805K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.